RPRX
Repros Therapeutics Inc.
RPRX
RPRX
Delisted
RPRX was delisted on the 31st of January, 2018.
30 hedge funds and large institutions have $3.33M invested in Repros Therapeutics Inc. in 2017 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
30
Holding in Top 10
–
Calls
$14K
Puts
–
Top Buyers
| 1 | +$435K | |
| 2 | +$61K | |
| 3 | +$16K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$10K |
| 5 |
Bank of New York Mellon
New York
|
+$9.87K |
Top Sellers
| 1 | -$216K | |
| 2 | -$208K | |
| 3 | -$76K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$43.8K |
| 5 |
VF
Virtu Financial
New York
|
-$42K |